A mysterious drug-resistant fungal infection has sickened hundreds of people in the U.S. in recent years. Dr. Neeta Ogden joins CBSN to discuss where this infection comes from and why it's spreading.
According to the Centers for Disease Control and Prevention (CDC), 30–60% of people with Candida auris infections have died. However, many of these people had other serious illnesses that also increased their risk of death.
Nearly 50% of Candida auris infected patients died within ninety (90) days.
90% of Candida auris cases are resistant to at least one antifungal.
30% of Candida auris cases are resistant to two or more antifungals.
After a the death of a patient hospital room:
"Everything was positive — the walls, the bed, the doors, the curtains, the phones, the sink, the whiteboard, the poles, the pump. The mattress, the bed rails, the canister holes, the window shades, the ceiling, everything in the room was positive."
"This is a very real thing folks. The worse thing about it is that it is spreading through health workers and hospitals. As we destroy the microbe world with our chemicals and destruction of habitats these new bugs are filling in the gaps where they were once contained."
"Oh, it's well beyond the tri-state area already. Hitting the largest urban areas-New York, Chicago, Los Angeles and moving into populous states. What I remember from Bio2 was how big of a pain in the ass fungi are-they can be more insidious than bacteria-yeah, I know bacteria is technically a specialized fungus- and even viruses. I'm going to make a strong effort to stay healthy and out of hospitals. This fungi could ramp up and race across the country in weeks."
Resistant infections are more expensive to treat:
US$16,000 to treat drug-sensitive infection (MSSA) with a 11.6% mortality rate.
US$35,000 to treat drug-resistant infection (MRSA) with a 24% mortality rate.